BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 26097183)

  • 1. A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation.
    Papageorgiou A; Mavragani CP; Nezos A; Zintzaras E; Quartuccio L; De Vita S; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
    Arthritis Rheumatol; 2015 Oct; 67(10):2732-41. PubMed ID: 26097183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients.
    Nezos A; Gkioka E; Koutsilieris M; Voulgarelis M; Tzioufas AG; Mavragani CP
    J Immunol Res; 2018; 2018():6923213. PubMed ID: 30662920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
    Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
    J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes.
    Mavragani CP; Nezos A; Sagalovskiy I; Seshan S; Kirou KA; Crow MK
    J Autoimmun; 2018 Mar; 88():75-82. PubMed ID: 29074164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of dendritic cell immunoreceptor (DCIR) polymorphisms in susceptibility of systemic lupus erythematosus and primary Sjogren's syndrome.
    Liu M; Wu X; Liu X; He J; Su Y; Guo J; Li Z
    Hum Immunol; 2015 Nov; 76(11):808-11. PubMed ID: 26429306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TREX1 variants in Sjogren's syndrome related lymphomagenesis.
    Nezos A; Makri P; Gandolfo S; De Vita S; Voulgarelis M; Crow MK; Mavragani CP
    Cytokine; 2020 Aug; 132():154781. PubMed ID: 31326279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
    Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
    Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type.
    Fabris M; Dolcetti R; Pasini E; Quartuccio L; Pontarini E; Salvin S; Ponzoni M; Scott CA; De Vita S
    Clin Exp Rheumatol; 2014; 32(1):61-5. PubMed ID: 24447326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy.
    De Vita S; Quartuccio L; Salvin S; Picco L; Scott CA; Rupolo M; Fabris M
    Clin Exp Rheumatol; 2014; 32(4):490-4. PubMed ID: 24802131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy.
    De Vita S; Quartuccio L; Salvin S; Corazza L; Zabotti A; Fabris M
    Rheumatology (Oxford); 2012 Apr; 51(4):627-33. PubMed ID: 22210656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of Fas and Fas-L mutations in patients with lymphoproliferative disorders associated with Sjögren's syndrome and type II mixed cryoglobulinemia.
    Bertolo F; De Vita S; Dolcetti R; Carbone A; Ferraccioli GF; Bartoli E; Boiocchi M
    Clin Exp Rheumatol; 1999; 17(3):339-42. PubMed ID: 10410268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
    Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
    Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
    Shah NR; Noll BD; Stevens CB; Brennan MT; Mougeot FB; Mougeot JC
    Arthritis Res Ther; 2017 Aug; 19(1):192. PubMed ID: 28818099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study.
    Pollard RP; Pijpe J; Bootsma H; Spijkervet FK; Kluin PM; Roodenburg JL; Kallenberg CG; Vissink A; van Imhoff GW
    J Rheumatol; 2011 Oct; 38(10):2198-208. PubMed ID: 21844152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial Risk of Sjögren's Syndrome and Co-aggregation of Autoimmune Diseases in Affected Families: A Nationwide Population Study.
    Kuo CF; Grainge MJ; Valdes AM; See LC; Luo SF; Yu KH; Zhang W; Doherty M
    Arthritis Rheumatol; 2015 Jul; 67(7):1904-12. PubMed ID: 25940005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis.
    Nezos A; Mavragani CP
    J Immunol Res; 2015; 2015():754825. PubMed ID: 26550578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical and laboratory characteristics of Sjögren's syndrome that progresses to systemic lupus erythematosus: a retrospective case-control study.
    Yang Y; Li Z; Wang L; Zhang F
    Int J Rheum Dis; 2013 Apr; 16(2):173-7. PubMed ID: 23773641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of systemic lupus erythematosus and Sjögren's syndrome].
    Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
    Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome.
    Gottenberg JE; Sellam J; Ittah M; Lavie F; Proust A; Zouali H; Sordet C; Sibilia J; Kimberly RP; Mariette X; Miceli-Richard C
    Arthritis Res Ther; 2006; 8(1):R30. PubMed ID: 16507129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of endometriosis in women with systemic lupus erythematosus and Sjogren's syndrome.
    Matorras R; Ocerin I; Unamuno M; Nieto A; Peiró E; Burgos J; Expósito A
    Lupus; 2007; 16(9):736-40. PubMed ID: 17728368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.